Imaflex Price To Sales Ratio vs Free Cash Flow Yield Analysis

IFX Stock

CAD 1.46 0.06 4.29%

Imaflex financial indicator trend analysis is infinitely more than just investigating Imaflex recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imaflex is a good investment. Please check the relationship between Imaflex Price To Sales Ratio and its Free Cash Flow Yield accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imaflex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Price To Sales Ratio vs Free Cash Flow Yield

Price To Sales Ratio vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Imaflex Price To Sales Ratio account and Free Cash Flow Yield. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Imaflex's Price To Sales Ratio and Free Cash Flow Yield is -0.16. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Imaflex, assuming nothing else is changed. The correlation between historical values of Imaflex's Price To Sales Ratio and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Imaflex are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Price To Sales Ratio i.e., Imaflex's Price To Sales Ratio and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

-0.16

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Imaflex stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Imaflex sales, a figure that is much harder to manipulate than other Imaflex multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Imaflex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imaflex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imaflex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Imaflex's Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 8.69 in 2024, whereas Tax Provision is likely to drop slightly above 289.4 K in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	411.4K	449.4K	593.9K	610.3K
Depreciation And Amortization	3.8M	4.1M	4.6M	2.3M

Interest Expense Depreciation And Amortization

Imaflex fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Cash	Current Deferred Revenue	Other Liab	Net Tangible Assets
Total Assets		0.45	0.53	0.27	0.97	0.96	0.07	0.94	0.26	0.95	-0.04	0.35	0.72	-0.66	0.69	0.69	0.64	-0.39	0.61	0.72	0.07	0.7	0.43	0.46	0.6	0.81
Short Long Term Debt Total	0.45		0.27	0.78	0.26	0.37	0.82	0.13	0.65	0.34	-0.13	-0.33	0.72	-0.08	0.54	0.68	0.44	-0.2	0.9	0.52	0.69	0.68	-0.21	0.63	-0.07	0.1
Other Current Liab	0.53	0.27		0.21	0.55	0.35	-0.16	0.49	0.08	0.33	-0.62	0.55	0.76	0.11	0.39	0.78	0.56	-0.57	0.39	0.81	-0.06	0.69	0.6	0.62	0.22	0.6
Total Current Liabilities	0.27	0.78	0.21		0.09	0.13	0.64	-0.04	0.86	0.12	-0.07	-0.29	0.59	0.05	0.1	0.6	0.3	-0.05	0.81	0.49	0.92	0.67	-0.16	0.54	-0.01	-0.05
Total Stockholder Equity	0.97	0.26	0.55	0.09		0.95	-0.14	0.99	0.07	0.93	-0.09	0.5	0.64	-0.63	0.63	0.62	0.57	-0.35	0.44	0.69	-0.1	0.62	0.57	0.37	0.66	0.88
Property Plant And Equipment Net	0.96	0.37	0.35	0.13	0.95		0.09	0.93	0.14	1.0	0.14	0.23	0.57	-0.77	0.7	0.5	0.58	-0.37	0.52	0.52	0.0	0.51	0.3	0.35	0.67	0.78
Net Debt	0.07	0.82	-0.16	0.64	-0.14	0.09		-0.24	0.6	0.09	0.23	-0.81	0.31	-0.1	0.36	0.24	0.29	-0.12	0.69	0.0	0.66	0.28	-0.73	0.32	-0.21	-0.28
Retained Earnings	0.94	0.13	0.49	-0.04	0.99	0.93	-0.24		-0.05	0.92	-0.04	0.55	0.53	-0.65	0.58	0.52	0.5	-0.31	0.32	0.61	-0.2	0.52	0.59	0.27	0.7	0.89
Accounts Payable	0.26	0.65	0.08	0.86	0.07	0.14	0.6	-0.05		0.15	0.11	-0.36	0.47	-0.11	0.22	0.49	0.29	-0.15	0.77	0.37	0.67	0.56	-0.25	0.43	-0.01	-0.08
Non Current Assets Total	0.95	0.34	0.33	0.12	0.93	1.0	0.09	0.92	0.15		0.19	0.2	0.54	-0.8	0.7	0.48	0.58	-0.39	0.51	0.48	-0.02	0.49	0.27	0.33	0.67	0.76
Non Currrent Assets Other	-0.04	-0.13	-0.62	-0.07	-0.09	0.14	0.23	-0.04	0.11	0.19		-0.52	-0.47	-0.58	0.02	-0.48	-0.03	0.01	-0.04	-0.54	0.05	-0.39	-0.55	-0.33	0.17	-0.19
Cash And Short Term Investments	0.35	-0.33	0.55	-0.29	0.5	0.23	-0.81	0.55	-0.36	0.2	-0.52		0.21	0.07	-0.02	0.29	-0.02	-0.06	-0.23	0.53	-0.43	0.22	0.99	0.09	0.27	0.58
Common Stock Shares Outstanding	0.72	0.72	0.76	0.59	0.64	0.57	0.31	0.53	0.47	0.54	-0.47	0.21		-0.05	0.63	0.95	0.67	-0.33	0.82	0.9	0.34	0.91	0.33	0.81	0.29	0.6
Short Term Investments	-0.66	-0.08	0.11	0.05	-0.63	-0.77	-0.1	-0.65	-0.11	-0.8	-0.58	0.07	-0.05		-0.39	-0.01	-0.4	0.33	-0.19	0.0	0.09	-0.08	0.06	0.09	-0.41	-0.34
Non Current Liabilities Total	0.69	0.54	0.39	0.1	0.63	0.7	0.36	0.58	0.22	0.7	0.02	-0.02	0.63	-0.39		0.6	0.57	-0.48	0.67	0.49	-0.12	0.53	0.04	0.55	0.44	0.67
Inventory	0.69	0.68	0.78	0.6	0.62	0.5	0.24	0.52	0.49	0.48	-0.48	0.29	0.95	-0.01	0.6		0.61	-0.31	0.8	0.96	0.33	0.97	0.4	0.73	0.28	0.62
Other Current Assets	0.64	0.44	0.56	0.3	0.57	0.58	0.29	0.5	0.29	0.58	-0.03	-0.02	0.67	-0.4	0.57	0.61		-0.48	0.56	0.51	0.07	0.56	0.05	0.52	0.31	0.44
Other Stockholder Equity	-0.39	-0.2	-0.57	-0.05	-0.35	-0.37	-0.12	-0.31	-0.15	-0.39	0.01	-0.06	-0.33	0.33	-0.48	-0.31	-0.48		-0.32	-0.23	0.16	-0.24	-0.04	-0.38	-0.16	-0.3
Total Liab	0.61	0.9	0.39	0.81	0.44	0.52	0.69	0.32	0.77	0.51	-0.04	-0.23	0.82	-0.19	0.67	0.8	0.56	-0.32		0.66	0.62	0.82	-0.1	0.73	0.25	0.36
Total Current Assets	0.72	0.52	0.81	0.49	0.69	0.52	0.0	0.61	0.37	0.48	-0.54	0.53	0.9	0.0	0.49	0.96	0.51	-0.23	0.66		0.23	0.94	0.63	0.66	0.34	0.7
Short Term Debt	0.07	0.69	-0.06	0.92	-0.1	0.0	0.66	-0.2	0.67	-0.02	0.05	-0.43	0.34	0.09	-0.12	0.33	0.07	0.16	0.62	0.23		0.43	-0.32	0.3	-0.08	-0.24
Net Receivables	0.7	0.68	0.69	0.67	0.62	0.51	0.28	0.52	0.56	0.49	-0.39	0.22	0.91	-0.08	0.53	0.97	0.56	-0.24	0.82	0.94	0.43		0.34	0.66	0.32	0.59
Cash	0.43	-0.21	0.6	-0.16	0.57	0.3	-0.73	0.59	-0.25	0.27	-0.55	0.99	0.33	0.06	0.04	0.4	0.05	-0.04	-0.1	0.63	-0.32	0.34		0.19	0.28	0.61
Current Deferred Revenue	0.46	0.63	0.62	0.54	0.37	0.35	0.32	0.27	0.43	0.33	-0.33	0.09	0.81	0.09	0.55	0.73	0.52	-0.38	0.73	0.66	0.3	0.66	0.19		0.21	0.39
Other Liab	0.6	-0.07	0.22	-0.01	0.66	0.67	-0.21	0.7	-0.01	0.67	0.17	0.27	0.29	-0.41	0.44	0.28	0.31	-0.16	0.25	0.34	-0.08	0.32	0.28	0.21		0.8
Net Tangible Assets	0.81	0.1	0.6	-0.05	0.88	0.78	-0.28	0.89	-0.08	0.76	-0.19	0.58	0.6	-0.34	0.67	0.62	0.44	-0.3	0.36	0.7	-0.24	0.59	0.61	0.39	0.8

Click cells to compare fundamentals

Imaflex Account Relationship Matchups

Imaflex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.4M	54.1M	65.0M	72.0M	83.5M	87.7M
Short Long Term Debt Total	16.4M	9.8M	9.6M	8.0M	11.4M	10.9M
Other Current Liab	1.9M	3.2M	3.3M	3.3M	2.1M	1.4M
Total Current Liabilities	13.6M	9.8M	14.3M	11.8M	14.4M	12.9M
Total Stockholder Equity	29.7M	36.0M	45.1M	55.1M	55.9M	58.7M
Property Plant And Equipment Net	28.6M	25.9M	24.5M	37.8M	47.8M	50.2M
Net Debt	16.4M	6.6M	1.1M	502.8K	10.6M	9.7M
Retained Earnings	15.6M	21.9M	30.3M	39.4M	39.9M	41.9M
Accounts Payable	4.1M	3.9M	5.6M	3.4M	6.4M	5.6M
Non Current Assets Total	29.8M	27.4M	26.3M	40.0M	55.1M	57.8M
Non Currrent Assets Other	(2.2M)	(1.5M)	(3.3M)	(3.4M)	1.8M	1.8M
Cash And Short Term Investments	60.9K	3.2M	8.5M	7.5M	799.1K	1.5M
Common Stock Shares Outstanding	50.7M	50.7M	51.6M	51.9M	52.0M	45.7M
Liabilities And Stockholders Equity	53.4M	54.1M	65.0M	72.0M	83.5M	87.7M
Non Current Liabilities Total	10.1M	8.3M	5.6M	5.1M	13.2M	6.7M
Inventory	11.8M	11.7M	14.9M	12.2M	13.2M	8.7M
Other Current Assets	236.5K	238.9K	204.8K	235.6K	343.2K	360.3K
Other Stockholder Equity	1.6M	1.7M	2.2M	3.1M	1.0	0.95
Total Liab	23.7M	18.1M	19.9M	16.8M	27.6M	19.7M
Total Current Assets	23.6M	26.6M	38.7M	32.0M	28.4M	20.2M
Short Term Debt	7.6M	2.7M	5.3M	5.1M	5.9M	5.9M
Net Receivables	11.5M	11.5M	15.1M	12.1M	14.1M	10.5M
Cash	60.9K	3.2M	8.5M	7.5M	799.1K	1.5M
Accumulated Other Comprehensive Income	597.6K	484.6K	2.2M	3.1M	3.0M	3.1M
Other Liab	1.2M	1.2M	1.4M	2.1M	2.4M	1.5M
Net Tangible Assets	28.5M	34.4M	43.3M	52.9M	60.9M	30.7M
Good Will	487.6K	478.0K	476.0K	508.5K	496.6K	528.9K
Short Long Term Debt	6.5M	1.9M	4.5M	4.2M	4.2M	4.2M
Intangible Assets	732.2K	1.1M	1.3M	1.7M	1.8M	1.2M
Property Plant Equipment	28.6M	25.9M	24.5M	37.8M	43.4M	25.1M
Long Term Debt	6.4M	5.5M	3.5M	1.7M	1.6M	1.5M
Capital Lease Obligations	3.5M	2.4M	1.6M	2.1M	7.2M	7.6M
Net Invested Capital	42.6M	43.4M	53.1M	61.0M	60.1M	52.7M
Net Working Capital	10.0M	16.8M	24.4M	20.3M	14.0M	16.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC